Scientists at UCLA have created a new kind of immune cell therapy that could change how advanced kidney cancer is treated. Unlike most current therapies that need to be custom-made for each patient, this one is ready to use right out of the lab. Called AlloCAR70 NKT, it’s built from stem cells and trained to hunt down a protein named CD70, which is often found on kidney cancer cells. Traditional CAR T therapies have had a tough time fighting solid tumors because they’re complex to make and don’t

Jaxson Dart visits one of our Tackle Kids Cancer MVPs (Most Valiant Patients) Giuseppe at the Joseph M. Sanzari Children's Hospital during our annual Halloween visit | New York Giants